These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10648415

  • 1. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.
    Blood; 2000 Feb 01; 95(3):999-1006. PubMed ID: 10648415
    [Abstract] [Full Text] [Related]

  • 2. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
    Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.
    Exp Hematol; 2000 May 01; 28(5):558-68. PubMed ID: 10812246
    [Abstract] [Full Text] [Related]

  • 3. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun 01; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 4. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.
    Eur J Immunol; 1998 Jan 01; 28(1):90-103. PubMed ID: 9485189
    [Abstract] [Full Text] [Related]

  • 5. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 01; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

  • 6. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G.
    J Immunol; 2004 Jan 15; 172(2):954-63. PubMed ID: 14707068
    [Abstract] [Full Text] [Related]

  • 7. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules.
    Van den Hove LE, Van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, Ceuppens JL.
    Leukemia; 1997 Apr 15; 11(4):572-80. PubMed ID: 9096698
    [Abstract] [Full Text] [Related]

  • 8. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L, Plumas J, Jacob MC, Bost F, Molens JP, Sotto JJ, Bensa JC.
    Exp Hematol; 1999 Mar 15; 27(3):479-88. PubMed ID: 10089910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
    Rodriguez JM, Elias F, Montaner A, Flo J, Lopez RA, Zorzopulos J, Franco RJ, Lenial SP, Lopez Salón M, Pirpignani ML, Solimano J, Garay G, Riveros D, Fernandez J, Cacchione R, Dupont J.
    Medicina (B Aires); 2006 Mar 15; 66(1):9-16. PubMed ID: 16555722
    [Abstract] [Full Text] [Related]

  • 13. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C, De Fanis U, Sellitto A, Dalla Mora L, Chiurazzi F, Giunta R, Rotoli B, Lucivero G.
    Leuk Lymphoma; 2003 Nov 15; 44(11):1963-71. PubMed ID: 14738151
    [Abstract] [Full Text] [Related]

  • 14. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M, Takahashi TA, Azuma M, Ogiso C, Maekawa TL, Yagita H, Okumura K, Sekiguchi S.
    Blood; 1996 Mar 15; 87(6):2386-93. PubMed ID: 8630402
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G.
    Eur J Immunol; 2001 Oct 15; 31(10):3026-37. PubMed ID: 11592079
    [Abstract] [Full Text] [Related]

  • 16. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
    Askew D, Chu RS, Krieg AM, Harding CV.
    J Immunol; 2000 Dec 15; 165(12):6889-95. PubMed ID: 11120813
    [Abstract] [Full Text] [Related]

  • 17. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R, Lenert P.
    J Immunol; 2005 Feb 15; 174(4):2429-34. PubMed ID: 15699180
    [Abstract] [Full Text] [Related]

  • 18. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar 15; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.